Recurrent Fever, Infections, Immune Disorders, and Autoinflammatory Diseases




The immune system functions to prevent and retard the local establishment or systemic dissemination of bacteria, viruses, fungi, and protozoa. Furthermore, it must accomplish this task without excessive inflammation or the development of autoimmunity. The immune system has four primary components:



  • 1.

    Antibody-mediated immunity (humoral or B cell immunity) is mediated by bone marrow-derived B lymphocytes and plasma cells (differentiated antibody-producing cells), which release antibodies (immunoglobulins) into secretions, plasma, and interstitial spaces. Antibodies work to opsonize and promote phagocytosis of organisms, neutralize toxins, and lyse pathogens (with the aid of complements).


  • 2.

    Cell-mediated immunity (T cell immunity) is mediated by thymus-derived T lymphocytes (i.e., CD4 and CD8 T cells) that are activated by antigen-presenting cells (e.g., dendritic cells, macrophages) and antigens. Although T cells do not produce immunoglobulin, CD4 T cells are necessary for optimal B cell function. CD4 T cells also express cytokines that activate phagocytes to efficiently clear intracellular pathogens. CD8 T cells lyse virally infected cells.


  • 3.

    The phagocytic system consists of tissue macrophages and dendritic cells, as well as blood-borne monocytes and neutrophils. In response to specific signals, phagocytes ingest and kill invading microorganisms. Dendritic cells also serve as antigen-presenting cells for T cells.


  • 4.

    The complement system acts synergistically with antibodies and the remainder of the immune system to help clear microbial infections both directly (complement-mediated cytolysis) and indirectly (recruitment of phagocytic cells, opsonization of microbes).



The differential diagnosis for patients with recurrent infections is formidable in view of the complexity of the immune system. The different arms of the immune system are interconnected, thus similar infections may occur as a manifestation of phagocyte, humoral, cell-mediated, or complement disorders that can be inherited or acquired ( Table 41.1 ). Alternatively, highly characteristic infections can point to a defect in a particular arm of the immune system ( Table 41.2 ). Most patients with recurrent infections do not have an underlying identifiable primary immunodeficiency, but they frequently have allergic rhinitis, asthma, or other risks for recurrent infections ( Table 41.3 ). Because of the low probability of identifying a discrete immune defect, the primary physician faces the difficult decision about the extent of the evaluation and which patients merit a complete evaluation. In addition, other genetic defects in the immune system result in recurrent episodes of spontaneous inflammation (i.e., autoinflammatory disorders ), or immune dysregulation and autoimmunity , and these can often be mistaken as recurrent infections.



TABLE 41.1

Cause and Mechanism of Recurrent Infection in Immunodeficiency States




























































Disorder Pathogen Deficiency
Primary Immunodeficiencies
Humoral immunodeficiency syndromes (predominantly B cell defects) Bacterial pathogens, enteroviruses Reduced phagocytic efficiency, failure of lysis and agglutination of bacteria, inadequate neutralization of virus and bacterial toxins
Cellular immunodeficiency syndromes (predominantly T cell defects) CMV, VZV, Strongyloides stercoralis; Mycobacterium, Listeria, Nocardia; Cryptococcus, Candida species; Pneumocystis carinii Absence of or impaired delayed hypersensitivity response; absence of T cell cooperation for B cell synthesis of antibodies to T cell–specific antigens; absence of T cell cytokines that activate mononuclear phagocytes, failure of T cell clearance of viruses
Complement Deficiencies
C1, C2, C3, C4, and factor B Streptococcus pyogenes, Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Klebsiella species Defective chemotaxis and opsonization of microbes
C5-C8 and properdin deficiencies Neisseria meningitidis, Neisseria gonorrhoeae Defective membrane attack mechanism
Phagocyte Defects
Neutropenia (ANC < 500/mm 3 ) Pyogenic bacteria or fungi , Pseudomonas species , Staphylococcus aureus Decreased neutrophil numbers
Chronic granulomatous disease Catalase-positive organisms, e.g., S. aureus, Serratia species, Burkholderia cepacia, Nocardia species , Candida species, Aspergillus species Impaired neutrophil bactericidal activity secondary to impaired production of hydrogen peroxide
Secondary Immunodeficiencies
AIDS CMV, VZV, adenovirus, HBV, Giardia lamblia, Entamoeba histolytica, Mycobacterium avium–intracellulare, Toxoplasma gondii, Mycobacterium tuberculosis, Cryptococcus neoformans, Pneumocystis jirovecii; Campylobacter, Candida, Isospora, Aspergillus, Nocardia, Strongyloides, and Cryptosporidium species Retrovirus infections transmitted by bodily fluid impair T cell response, reduced T helper cell numbers
Cancer VZV, HSV, Escherichia coli; Pseudomonas, Klebsiella, Listeria, Cryptococcus, Pneumocystis, and Mycobacterium species Neutropenia, lymphopenia, impaired cellular immunity
Immunosuppression HSV, VZV, CMV, EBV, hepatitis virus, Pseudomonas species, E. coli; Klebsiella, Acinetobacter, Serratia, Candida, Aspergillus, Mucor, and Cryptococcus species Dependent on agent used, leads often to impaired cellular immunity and neutropenia, lymphopenia
Transplantation CMV, HSV, VZV, hepatitis virus, S. aureus; Pseudomonas, Klebsiella, Candida, Aspergillus, Nocardia , and Pneumocystis species; EBV Related to use of immunosuppressive agents
Malnutrition Measles, HSV, VZV, Mycobacterium species Impaired T cell function, reduction in complement activity

AIDS, acquired immunodeficiency syndrome; ANC, absolute neutrophil count; CMV, cytomegalovirus; EBV, Epstein-Barr virus; HBV, hepatitis B virus; HSV, herpes simplex virus; VZV, varicella-zoster virus.


TABLE 41.2

Characteristic Pathogens Affecting Immunocompromised Patients























I. Humoral Defects


  • A.

    Antibody Deficiency (B Cell Defects)



    • 1.

      Bacteria




      • Staphylococcus aureus (sepsis, sinopulmonary infection)



      • Haemophilus influenzae (sepsis, meningitis, arthritis, sinopulmonary infection)



      • Streptococcus pneumoniae (sepsis, meningitis, arthritis)



      • Pseudomonas aeruginosa (sepsis, pneumonia)



      • Mycoplasma species (arthritis, pneumonia)



      • Salmonella species (enteritis)



      • Campylobacter species (enteritis)



    • 2.

      Viruses




      • Enterovirus, including polio vaccine (encephalitis, paralysis, myositis, arthritis)



      • Rotavirus (enteritis)



    • 3.

      Protozoa




      • Giardia lamblia (enteritis)




  • B.

    Complement Deficiencies



    • 1.

      C1, C2, C3, C4, factor B




      • S. pyogenes



      • S. pneumoniae, S. aureus, H. influenzae, Neisseria meningitidis, Klebsiella species (sepsis, meningitis, arthritis)



    • 2.

      C5-8, properdin deficiency




      • N. meningitidis, N. gonorrhoeae (meningitis, sepsis, arthritis)



II. Combined B and T Cell Defects (Congenital, Acquired Immunodeficiency Syndrome, Immunosuppression Malignancies)


  • A.

    Bacteria




    • Listeria monocytogenes (sepsis, meningitis)



    • Salmonella (sepsis)



    • Mycobacterium tuberculosis (pneumonia, disseminated disease)



    • Atypical mycobacteria ( Mycobacterium avium, Mycobacterium intracellulare ) (sepsis, pneumonia, disseminated disease)



    • Nocardia species (pneumonia, CNS infection)



    • Legionella species (pneumonia)



  • B.

    Fungi




    • Cryptococcus neoformans (sepsis, meningitis)



    • Histoplasma capsulatum (pneumonia, disseminated disease)



    • Coccidioides immitis (pneumonia, meningitis)



  • C.

    Viruses




    • Varicella-zoster (cutaneous and CNS infection, pneumonia, hepatitis)



    • Cytomegalovirus (bone marrow infection, pneumonia, retinitis, esophagitis, colitis, CNS infection)



    • Herpes simplex (CNS infection, pneumonia, esophagitis, hepatitis, disseminated disease)



    • Epstein-Barr virus (lymphoma)



    • Measles (pneumonia, encephalitis)



    • Polyomavirus BK (hemorrhagic cystitis, ureteric stenosis, renal insufficiency)



    • Polyomavirus JC (progressive multifocal leukoencephalopathy)



  • D.

    Protozoa




    • Pneumocystis carinii (pneumonia, rare extrapulmonary spread)



    • Toxoplasma gondii (CNS infection, myocarditis)



    • Cryptosporidium species (enteritis)



  • E.

    Helminths




    • Strongyloides stercoralis (enteritis, pneumonia, sepsis, meningitis)


III. Neutropenia (Severe Chronic Neutropenia, Aplastic Anemia, Myelosuppression, Myelophthisis Myelosuppressive Agents, Bone Marrow Transplantation)


  • A.

    Bacteria




    • Escherichia coli (sepsis, pneumonia, pyelonephritis)



    • Klebsiella pneumoniae (sepsis, pneumonia)



    • P. aeruginosa (sepsis, pneumonia, cutaneous lesions)



    • Mixed anaerobic and aerobic enteric bacteria (typhlitis, perianal abscess)



    • S. aureus (sepsis, cellulitis, soft tissue infection)



    • Staphylococcus epidermidis (line infection)



    • Corynebacterium JK strain (sepsis)



    • α-Hemolytic streptococci (sepsis)



  • B.

    Fungi




    • Candida species (sepsis, pneumonia, ophthalmitis, liver and spleen abscesses)



    • Aspergillus species (sepsis, pneumonia, sinusitis, CNS infection, cutaneous lesions)



    • Mucor (pneumonia, sinusitis, CNS infection)



    • Fusarium species (sepsis, cutaneous lesions, pneumonia)



    • Alternaria species (sepsis, cutaneous lesions)


IV. Phagocytic Dysfunction


  • A.

    Chronic Granulomatous Disease




    • Bacteria (soft tissue, lymphadenitis, pneumonia, osteomyelitis)



    • Catalase-positive organisms, e.g., S. aureus, Serratia marcescens, Burkholderia cepacia, Nocardia species



    • Fungi (pneumonia, liver infection, soft tissue), Candida species, Aspergillus species)



  • B.

    Other Phagocyte Defects (Leukocyte Adhesion Deficiency Hyperimmunoglobulin E, Chédiak-Higashi syndrome, specific granule deficiency, Rac-2 deficiency)




    • Bacteria (soft tissue, pneumonia, lymphadenitis)



    • Pseudomonas species, S. aureus, E. coli, Klebsiella, Enterobacter species



    • Fungus (pneumonia)



    • Candida infection if diabetic


V. Splenic Dysfunction (e.g., Asplenia, Sickle Cell Anemia)


  • A.

    Bacteria




    • S. pneumoniae (sepsis, meningitis)



    • H. influenzae type b (sepsis, meningitis)



    • N. meningitidis (sepsis, meningitis)



    • Capnocytophaga canimorsus



  • B.

    Protozoa




    • Babesiosis



    • Malaria



CNS, central nervous system.


TABLE 41.3

Infections in Patients without Primary Immunodeficiency Syndromes




















































































































Predisposing Causes Organism and Type of Infection
Alteration of Mucocutaneous Barriers
Indwelling Catheter
Central venous catheter (Broviac, Hickman) Staphylococcus aureus ; S. epidermidis ; and Bacteroides , Candida , Pseudomonas species: bacteremia, fungemia
Urinary catheter Escherichia coli , Enterococcus species, Staphylococcus saprophyticus : pyelonephritis
Tenckhoff catheter (continuous ambulatory peritoneal dialysis) Staphylococcus epidermidis , S. aureus , E. coli , Pseudomonas aeruginosa , Candida species: peritonitis
Cerebrospinal fluid shunts S. epidermidis , S. aureus , diphtheroid, Bacillus species: meningitis
Aspirated pulmonary foreign body S. aureus , anaerobes: pneumonia, pulmonary abscess, empyema
Burns P. aeruginosa , S. epidermidis , Candida species: cutaneous lesions, sepsis
Inhalation Therapy: Contaminated Solutions P. aeruginosa, Serratia marcescens, Legionella species: pneumonia
Surgical Wounds
Abdominal Gram-negative bacteria, S. aureus, S. epidermidis, Candida species: peritonitis
Nongastrointestinal S. aureus, S. epidermidis, streptococci, gram-negative bacteria: wound abscess, sepsis
Fistula-Sinus Communications
Neurocutaneous fistula S. aureus, S. epidermidis, E. coli : meningitis
Neuroenteric fistula Gram-negative bacteria: meningitis
Otic, facial sinus-meningeal sinus tract Pneumococcus: meningitis
Facial sinus fracture (CSF rhinorrhea) Pneumococcus: meningitis
Intravenous Drug Abuse S. aureus, P. aeruginosa, streptococci: endocarditis, osteomyelitis Hepatitis B, C, D viruses: AIDS
Prosthetic Devices
Cardiac valves S. epidermidis, streptococci, S. aureus , diphtheroid, Candida species: endocarditis
Pacemaker S. epidermidis, S. aureus, Candida species: subcutaneous pocket or endocardial infection
Chronic Disease
Malnutrition Measles; tuberculosis; herpes simplex virus; bacterial, parasitic, and viral diarrhea, gram-negative bacteria: sepsis, pneumonia
Cystic fibrosis S. aureus, Haemophilus influenzae, mucoid P. aeruginosa, Burkholderia cepacia; pneumonia
Diabetes mellitus Urinary tract infections, Mucor, and other fungi: sinus-orbital infection
Nephrotic syndrome Pnemococcus, E. coli: peritonitis
Uremia S. aureus, gram-negative bacteria, fungi: sepsis, soft tissue infection
Cirrhosis, ascites Pnemococcus, E. coli: peritonitis
Prolonged broad-spectrum antibiotic therapy Candida species, Enterococcus species, multidrug-resistant gram-negative or gram-positive bacteria: sepsis
Spinal cord injury Gram-negative or gram-positive bacteria: pneumonia, pyelonephritis, pressure sores, abscesses, osteomyelitis
Sickle cell anemia Pnemococcus: sepsis, meningitis, osteoarticular infection
Salmonella species, S. aureus: osteomyelitis
Congenital heart disease S. aureus, Streptococcus viridans group: endocarditis
Urinary tract anomaly E. coli, S. saprophyticus, Enterococcus species: pyelonephritis
Kartagener syndrome (dysmotile cilia) H. influenzae, Moraxella catarrhalis, pnemococcus: pneumonia, sinusitis
Eczema/atopic disease S. aureus, Streptococcus species, varicella, herpes simplex, molluscum: cutaneous infection, cellulitis
Protein-losing enteropathy (lymphangiectasia) Pneumococcus: sepsis, peritonitis
Giardia species: diarrhea
Periodontitis Fusobacterium species: cellulitis, facial space infection

AIDS, acquired immunodeficiency syndrome; CMV, cytomegalovirus; CSF, cerebrospinal fluid; EBV, Epstein-Barr virus; HIV, human immunodeficiency virus; HHV-6, human herpesvirus 6.


Although there are no established rules regarding immunologic work-up of a patient with infections, an evaluation should be considered for at least 1 of the following: (1) more than 2 systemic bacterial infections (sepsis, meningitis, osteomyelitis); (2) 2 or more serious respiratory infections (pneumonia, sinusitis) or bacterial infections (cellulitis, draining otitis media, lymphadenitis) per year; (3) the presence of an infection at an unusual site (hepatic or brain abscess); (4) infections with unusual pathogens ( Aspergillus pneumonia, disseminated candidiasis, or infection with Serratia marcescens , Nocardia species, or Burkholderia cepacia ); (5) infections of unusual severity; and (6) recurrent mycobacterial infections or invasive infections with atypical mycobacteria.


History and Physical Examination


History


The clinician must determine (1) the frequency, location, severity, and complications of the infections; (2) the accuracy of how infections were documented; (3) the presence or absence of a symptom-free interval; (4) the microbiologic features of any isolate; and (5) the response to antibiotic therapy. A single chronic infection may wax and wane with intermittent, inadequate treatment and may manifest as a series of infections. Furthermore, a detailed history can elucidate other risk factors for recurrent infections. Many nonimmune disorders are characterized by an increased susceptibility to infection that must also be considered (see Table 41.3 ). A detailed history can provide clues as to the likelihood and nature of a primary immune deficiency ( Table 41.4 ).



TABLE 41.4

Clinical Aids to the Diagnosis of Immunodeficiency























Suggestive of B Cell Defect (Humoral Immunodeficiency)



  • Recurrent bacterial infections of the upper and lower respiratory tracts



  • Recurrent skin infections, meningitis, osteomyelitis secondary to encapsulated bacteria (Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Neisseria meningitidis)



  • Paralysis after vaccination with live attenuated poliovirus



  • Reduced levels of immunoglobulins

Suggestive of T Cell Defect (Combined Immunodeficiency)



  • Systemic illness after vaccination with any live virus or bacille Calmette-Guérin (BCG)



  • Unusual life-threatening complication after infection with benign viruses (giant cell pneumonia with measles; varicella pneumonia)



  • Chronic oral candidiasis after 6 months of age



  • Chronic mucocutaneous candidiasis



  • Graft-versus-host disease after blood transfusion



  • Reduced lymphocyte counts for age



  • Low level of immunoglobulins



  • Absence of lymph nodes and tonsils



  • Small thymus



  • Chronic diarrhea



  • Failure to thrive



  • Recurrent infections with opportunistic organisms

Suggestive of Macrophage Dysfunction



  • Disseminated atypical mycobacterial infection, recurrent




    • Salmonella infection




  • Fatal infection after BCG vaccination

Congenital Syndromes with Immunodeficiency



  • Ataxia-telangiectasia: ataxia, telangiectasia



  • Autoimmune polyglandular syndrome: hypofunction of 1 or more endocrine organs, chronic mucocutaneous candidiasis



  • Cartilage-hair hypoplasia: short-limbed dwarfism, sparse hair, neutropenia



  • Wiskott–Aldrich syndrome: thrombocytopenia, male gender, eczema



  • Chédiak–Higashi syndrome: oculocutaneous albinism, nystagmus, recurrent bacterial infections, peripheral neuropathies



  • DiGeorge syndrome (22q deletion syndrome): unusual facies, heart defect, hypocalcemia

Suggestive of Asplenia



  • Heterotaxia, complex congenital heart disease, Howell–Jolly bodies on blood smear, sickle cell anemia



Perinatal History


The clinician should determine if there was exposure to maternal viral infection during gestation (human immunodeficiency virus [HIV], cytomegalovirus (CMV), herpes simplex virus, rubella), or a history of prematurity, blood transfusions, respiratory distress syndrome (with bronchopulmonary dysplasia), or other pertinent neonatal illnesses. Infants previously placed on ventilators may develop chronic obstructive lung disease (bronchopulmonary dysplasia), predisposing them to recurrent pulmonary infections. Most perinatal HIV infections are seen in children whose mother or mother’s partner has engaged in high-risk behavior (i.e., multiple sex partners or use of cocaine or intravenous drugs). Attention should be paid to the time of umbilical cord separation since infants with a history of delayed umbilical cord separation and recurrent episodes of sepsis or pneumonia should be evaluated for leukocyte adhesion deficiency .


Medical History


A variety of nonimmune medical issues can result in recurrent infections (see Table 41.3 ). Approximately 30% of children with recurrent sinopulmonary symptoms can be categorized as atopic (allergic on a hereditary basis). These subjects have normal growth and development, and episodes of recurrent illness may be afebrile, respond poorly to antibiotics, and be accompanied by upper respiratory symptoms such as coughing, sneezing, or wheezing. There may be a family history of atopic disease, and the patient’s past medical history may include episodic wheezing, protracted cough after upper respiratory tract infection (URI) hay fever, allergies to foods, or eczema. The physical examination of allergic school-aged children may reveal typical characteristics including the following: dark circles under the eyes; open mouth with dry lips; coated tongue; evidence of nasal obstruction; transverse nasal crease; boggy, pale nasal mucosa; mucus in the pharynx; posterior pharyngeal “cobblestoning”; and postnasal drip.


Malnutrition and specific vitamin deficiencies may alter immune cell function. Protein-losing states due to gastrointestinal (e.g., inflammatory bowel disease, protein-losing enteropathy) or renal disease (e.g., nephrotic syndrome) may lead to hypocomplementemia, hypogammaglobulinemia, and recurrent infections. Chronic treatment with corticosteroids and other immunosuppressants can result in acquired immunodeficiency and recurrent infections.


Anatomic Abnormalities


Recurrent infections in primary immune deficiencies typically affect different anatomic locations. Structural or anatomic defects often result in recurrent infections that are generally localized to the affected organ system. Approximately 10% of children with recurrent infections have an underlying chronic disease or a structural defect that predisposes them to recurrent infections (see Table 41.3 ).


Eustachian tube abnormalities or cleft palate result in recurrent or chronic otitis media; congenital heart disease results in an increased risk of endocarditis; and posterior urethral valves, vesicoureteral reflux, or ureteral pelvic junction obstruction results in recurrent urinary tract infections. Recurrent pneumonia may result from congenital malformations (trachea-esophageal fistulas, cystic adenomatoid malformation, or sequestration), from aspiration of a foreign body (peanut, small toys) or chronic aspiration (gastroesophageal reflux or swallowing disorders), and from bronchopulmonary dysplasia. Repeated pneumonias in dependent lobes warrant evaluation for recurrent aspiration. Chronic illnesses that result in recurrent pulmonary infections include cystic fibrosis, primary ciliary dyskinesia, or α 1 -antitrypsin deficiency. Recurrent sinus infections can occur due to anatomic defects of the sinuses (polyps, stenotic os). Endotracheal intubation predisposes the patient to recurrent pulmonary infections with nosocomial organisms. Right middle lobe syndrome and sequestered lung can appear as recurrent pneumonia in the same anatomic location.


Any direct communication to the cerebrospinal fluid that bypasses the blood–brain barrier predisposes patients to a central nervous system infection. Basilar skull fractures and dermal sinus tracts or fistulas may communicate with the subarachnoid space or neural tissue. Other conditions predisposing patients to opportunistic infections of the central nervous system include penetrating foreign body, cerebrospinal fluid shunts, myelomeningocele, and encephalocele. Local infections of the sinuses or of the middle ear may spread to contiguous structures to form cerebral abscesses or subdural-epidural empyema. Intravenous drug abuse, bacterial endocarditis, and heart disease with right-to-left shunt are associated with an increased risk of central nervous system infections.


Family History


Specific patterns of inheritance have been determined for a variety of immunologic defects. Genetic defects of immunity can be inherited as X-linked, autosomal recessive, or autosomal dominant disorders. Monogenic primary immunodeficiencies may exhibit reduced penetrance (some people with the genetic abnormality do not exhibit a clinical phenotype) and variable expressivity (different signs and symptoms with same genetic defect). A family history of unexplained infant deaths or serious infection should be sought, particularly in male infants since a number of important immune deficiencies are X-linked. Evidence of consanguinity should be sought as many serious primary immune deficiencies are autosomal recessive. Since allergic diseases can appear as recurrent infections, a family history of atopy is important. A child who has 1 allergic parent or 2 allergic parents is predisposed to allergic reactions by 25% and 50%, respectively.


Environmental History


The incidence of respiratory disease is increased in children exposed to cigarette or marijuana smoke or other noxious fumes (wood-burning stove) in the home. Respiratory and dermatologic findings are seen as a result of exposure to environmental allergens and toxins. Specific bacteriologic and parasitic exposures are associated with certain pets (i.e., Salmonella organisms and iguanas or turtles; psittacosis and birds; Bartonella organisms in kittens). A travel history may suggest exposure to unusual organisms that are regionally endemic, such as certain parasites and specific insect or animal bites, or to contaminated water. A move to a new house or to a new nursery school or exposure to a new babysitter, pet, or housekeeper may suggest possible allergic and infectious risks.


Physical Examination


The physical examination may provide important clues to the diagnosis of a primary immune deficiency (see Table 41.4 ). Longitudinal evaluation of height and weight are crucial in identifying infants with failure to thrive or acute weight loss. Chronic upper respiratory infections are suggested by scarred tympanic membranes, postnasal drip, and cervical adenopathy. Transverse nasal creases, circles under the eyes, and posterior pharyngeal “cobblestoning” suggest respiratory allergy. Recurrent cough, wheezing, digital clubbing, and chest deformity are suggestive of pulmonary disease. Mouth ulceration or stomatitis can be a sign of immune deficiency or autoinflammatory disorder. Auscultation of the apex of the heart in the right side of the thorax (dextrocardia) may be accompanied by ciliary motility abnormalities or asplenia. Lymphadenopathy, hepatosplenomegaly, pallor, wasting, and recent weight loss are suggestive of systemic disease. Absence of lymph tissue (tonsils and lymph nodes) is suggestive of a B cell deficiency, while absence of thymic tissue on chest radiograph in an infant is suggestive of T cell deficiency. Parotid enlargement with lymphadenopathy and hepatosplenomegaly is suggestive of HIV infection. Skin abnormalities including alopecia, eczema, pyoderma, and telangiectasia can be important clues. Evidence of hematologic disease, such as pallor, petechiae, and jaundice can be associated with immunodeficiencies. Generalized lymphadenopathy and splenomegaly may be suggestive of HIV disease, a phagocyte disorder with recurrent infections, or a lymphoproliferative disorder.


Diagnostic Categories


The information obtained from the history and physical examination is usually sufficient to make a tentative classification:



  • 1.

    The patient who is probably healthy.


  • 2.

    The atopic or allergic patient.


  • 3.

    The patient with a nonimmunologic defect in host defense (see Table 41.3 ).


  • 4.

    The patient with hereditary inflammatory disorders ( Table 41.5 ).



    TABLE 41.5

    Autoinflammatory Disorders































































































    Disease Genetic Defect/Presumed Pathogenesis Inheritance Affected Cells Functional Defects Associated Features
    Familial Mediterranean fever Mutations of MEFV (lead to gain of pyrin function, resulting in inappropriate IL-1β release) AR Mature granulocytes, cytokine-activated monocytes Decreased production of pyrin permits ASC-induced IL-1 processing and inflammation following subclinical serosal injury; macrophage apoptosis decreased Recurrent fever, serositis, and inflammation responsive to colchicine. Predisposes to vasculitis and inflammatory bowel disease
    Mevalonate kinase deficiency (hyper 0 IgD syndrome) Mutations of MVK (lead to a block in the mevalonate pathway). Interleukin-1β mediates the inflammatory phenotype AR Affecting cholesterol synthesis; pathogenesis of disease is unclear Periodic fever and leukocytosis with high IgD levels
    Muckle–Wells syndrome Mutations of NLRP3 (also called PYPAF1 or NALP3) lead to constitutive activation of the NLRP3 inflammasome AD PMNs, monocytes Defect in cryopyrin, involved in leukocyte apoptosis and NF-κB signaling and IL-1 processing Urticaria, SNHL, amyloidosis
    Familial cold autoinflammatory syndrome Mutations of NLRP3 (see above)
    Mutations of NLRP12
    AD PMNs, monocytes Same as above Nonpruritic urticaria, arthritis, chills, fever, and leukocytosis after cold exposure
    Neonatal-onset multisystem inflammatory disease (NOMID) or chronic infantile neurologic cutaneous and articular syndrome (CINCA) Mutations of NLRP3 (see above) PMNs, chondrocytes Same as above Neonatal-onset rash, chronic meningitis, and arthropathy with fever and inflammation
    TNF receptor–associated periodic syndrome (TRAPS) Mutations of TNFRSF1A (resulting in increased TNF inflammatory signaling) AD PMNs, monocytes Mutations of 55-kDa TNF receptor leading to intracellular receptor retention or diminished soluble cytokine receptor available to bind TNF Recurrent fever, serositis, rash, and ocular or joint inflammation
    Pyogenic sterile arthritis, pyoderma gangrenosum, acne (PAPA) syndrome Mutations of PSTPIP1 (also called C2BP1) (affects both pyrin and protein tyrosine phosphatase to regulate innate and adaptive immune responses) AD Hematopoietic tissues, upregulated in activated T cells Disordered actin reorganization leading to compromised physiologic signaling during inflammatory response Destructive arthritis, inflammatory skin rash, myositis
    Blau syndrome Mutations of NOD2 (also called CARD15) (involved in various inflammatory processes) AD Monocytes Mutations in nucleotide binding site of CARD15, possibly disrupting interactions with lipopolysaccharides and NF-κB signaling Uveitis, granulomatous synovitis, camptodactyly, rash, and cranial neuropathies, 30% develop Crohn disease
    Chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia (Majeed syndrome) Mutations of LPIN2 (increased expression of the proinflammatory genes) AR Neutrophils, bone marrow cells Undefined Chronic recurrent multifocal osteomyelitis, transfusion-dependent anemia, cutaneous inflammatory disorders
    Early-onset inflammatory bowel disease Mutations in IL-10 (results in increase of many proinflammatory cytokines) AR Monocyte/macrophage, activated T cells IL-10 deficiency leads to increase of TNFγ and other proinflammatory cytokines Enterocolitis, enteric fistulas, perianal abscesses, chronic folliculitis
    Early-onset inflammatory bowel disease Mutations in IL-10RA (see above) AR Monocyte/macrophage, activated T cells Mutation in IL-10 receptor alpha leads to increase of TNFγ and other proinflammatory cytokines Enterocolitis, enteric fistulas, perianal abscesses, chronic folliculitis
    Early-onset inflammatory bowel disease Mutations in IL-10RB (see above) AR Monocyte/macrophage, activated T cells Mutation in IL-10 receptor beta leads to increase of TNFγ and other proinflammatory cytokines Enterocolitis, enteric fistulas, perianal abscesses, chronic folliculitis

    AD, autosomal dominant; AR, autosomal recessive; Ig, immunoglobulin; IL, interleukin; NF-κB, nuclear factor-κB; PMN, polymorhonuclear neutrophil; SNHL, sensorineural hearing loss; TNF, tumor necrosis factor.


  • 5.

    The immunodeficient patient.



Patient Who Is Probably Healthy


Many healthy children have repeated minor infections, or have a relatively brief history of repeated infections, or a single prolonged illness from which recovery has been delayed. Most upper respiratory tract infections last less than 7 days, and duration of longer than 14 days is unusual. Most children younger than 1 year who have a large family or who attend daycare develop respiratory or gastrointestinal infections about 6 times during the 1st year of life. The onset of the recurrent infection may coincide with entry into day care, preschool, or kindergarten. The healthy child has normal growth and development before the illness and usually a normal physical examination finding. When a discrepancy exists between the severity of an illness as reported by the parent and the child’s physical appearance, it is often prudent to delay a detailed evaluation until more objective findings are documented by repeat examinations during acute episodes. Laboratory testing might include a complete blood cell count, inflammatory markers (i.e., erythrocyte sedimentation rate [ESR], C-reactive protein [CRP]) to exclude rheumatic disorders or occult infections, and measurement of immunoglobulin levels and vaccine specific titers as a screen. Cultures and imaging of the affected area may provide additional data. With reassurance of the parents, these children recover spontaneously. Simple measures, rather than a complex set of laboratory studies, are often the only treatment required.


Patient with Hereditary Inflammatory Disorders


Autoinflammatory syndromes , formerly known as periodic fever syndromes , are a heterogeneous and ever increasing group of rare inflammatory disorders that manifest with recurrent fevers and/or inflammatory episodes (see Table 41.5 ). Recurrent fevers or inflammation can often be mistaken for recurrent infections. Patients exhibit characteristic physical findings during these episodes, such as fever, various rashes, lymphadenopathy, aphthous stomatitis, arthritis, and serositis with abdominal, chest, or testicular pain. These episodes can be periodic or sporadic, but the characteristic features occur with each episode. Laboratory evaluation may show elevated white blood cell (WBC) counts and elevated inflammatory markers during the episode that typically resolve between episodes. Importantly, infectious work-ups are often repeatedly negative, and the patient is typically well between febrile episodes.


There are also an increasing number of disorders of immune dysregulation that have been described ( Table 41.6 ). Unlike autoinflammatory disorders, these disorders result in a failure to control T and B cell responses, resulting in autoimmunity . These disorders are not typically episodic, and once autoimmunity develops it continues until treated. Many of these disorders are also associated with immune deficiency and recurrent infection, thus patients experience recurrent infections simultaneously with autoimmune manifestations.



TABLE 41.6

Disorders of Immune Regulation




































































































































































Disease Genetic Defect/Presumed Pathogenesis Inheritance Circulating T Cells Circulating B Cells Functional Defect Associated Features
Perforin deficiency (FHL2) Mutations in PRF1 ; perforin is a major cytolytic protein AR Increased activated T cells Normal Decreased to absent NK and CTL activities (cytotoxicity) Fever, hepatosplenomegaly (HSMG), hemophagocytic lymphohistiocytosis (HLH), cytopenias
UNC13D/Munc13-4 deficiency (FHL3) Mutations in UNC13D ; required to prime vesicles for fusion AR Increased activated T cells Normal Decreased to absent NK and CTL activities (cytotoxicity and/or degranulation) Fever, HSMG, HLH, cytopenias
Syntaxin 11 deficiency (FHL4) Mutations in STX11 , required for secretory vesicle fusion with the cell membrane AR Increased activated T cells Normal Decreased NK activity (cytotoxicity and/or degranulation) Fever, HSMG, HLH, cytopenias
STXBP2/Munc18-2 deficiency (FHL5) Mutations in STXBP2 , required for secretory vesicle fusion with the cell membrane AR Increased activated T cells Normal Decreased NK and CTL activities (cytotoxicity and/or degranulation) Fever, HSMG, HLH, cytopenias
Chediak–Higashi syndrome Mutations in LYST , Impaired lysosomal trafficking AR Increased activated T cells Normal Decreased NK and CTL activities (cytotoxicity and/or degranulation) Partial albinism, recurrent infections, fever, HSMG, HLH, giant lysosomes, neutropenia, cytopenias, bleeding tendency, progressive neurologic dysfunction
Griscelli syndrome, type 2 Mutations in RAB27A encoding a GTPase that promotes docking of secretory vesicles to the cell membrane AR Normal Normal Decreased NK and CTL activities (cytotoxicity and/or degranulation) Partial albinism, fever, HSMG, HLH, cytopenias
SH2D1A deficiency (XLP1) Mutations in SH2D1A encoding an adaptor protein regulating intracellular signaling XL Normal or increased activated T cells Reduced memory B cells Partially defective NK cell and CTL cytotoxic activity Clinical and immunologic features triggered by EBV infection: HLH, lymphoproliferation, aplastic anemia, lymphoma, hypogammaglobulinemia, absent iNK T cells
XIAP deficiency (XLP2) Mutations in XIAP encoding an inhibitor of apoptosis XL Normal or increased activated T cells; low/normal iNK T cells Normal or reduced memory B cells Increased T cells susceptibility to apoptosis to CD95 and enhanced activation-induced cell death (AICD) EBV infection, splenomegaly, lymphoproliferation, HLH, colitis, IBD, hepatitis, low iNK T cells
IPEX, immune dysregulation, polyendocrinopathy, enteropathy X-linked Mutations in FOXP3 , encoding a T cell transcription factor XL Normal Normal Lack of (and/or impaired function of) CD4+ CD25+ FOXP3+ regulatory T cells (Tregs) Autoimmune enteropathy, early-onset diabetes, thyroiditis, hemolytic anemia, thrombocytopenia, eczema, elevated IgE, IgA
CD25 deficiency Mutations in IL2RA , encoding IL-2Rα chain AR Normal to decreased Normal No CD4+ C25+ cells with impaired function of Tregs Lymphoproliferation, autoimmunity. Impaired T cell proliferation
STAT5b deficiency Mutations in STAT5B , signal transducer, and transcription factor, essential for normal signaling from IL-2 and IL-15, key growth factors for T and NK cells AR Modestly decreased Normal Impaired development and function of γδ T cells, Tregs, and NK cells, low T cell proliferation Growth hormone–insensitive dwarfism, dysmorphic features, eczema, lymphocytic interstitial pneumonitis, autoimmunity
LRBA deficiency Mutations in LRBA (lipopolysaccharide responsive beige like anchor protein) AR Reduced I IgG and IgA in most Defect CTLA4 expression on surface Recurrent infections, inflammatory bowel disease, autoimmunity; EBV infections
CTLA4 Mutations or deletions in CLTA4 AD Variable IgG reduced Hypogammaglobulinemia Recurrent infections, autoimmune cytopenia, brain inflammation
APECED (APS-1), autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy Mutations in AIRE , encoding a transcription regulator needed to establish thymic self-tolerance AR Normal Normal AIRE/1 serves as checkpoint in the thymus for negative selection of autoreactive T cells and for generation of Tregs Autoimmunity: hypoparathyroidism hypothyroidism, adrenal insufficiency, diabetes, gonadal dysfunction, and other endocrine abnormalities, chronic mucocutaneous candidiasis, dental enamel hypoplasia, alopecia areata, enteropathy, pernicious anemia
ALPS–FAS Germinal mutations in TNFRSF6, encoding CD95/Fas cell surface apoptosis receptor AR Increased CD4 CD8 TCRα/β double negative (DN) T cells Normal, low memory B cells Apoptosis defect FAS mediated Splenomegaly, adenopathies, autoimmune cytopenias, increased lymphoma risk, IgG and IgA normal or increased, elevated FasL and IL-10, vitamin B 12
ALPS–FASLG Mutations in TNFSF6 , Fas ligand for CD95 apoptosis AR Increased DN T cells Normal Apoptosis defect FAS mediated Splenomegaly, adenopathies, autoimmune cytopenias, SLE, soluble FasL is not elevated
ALPS–caspase 10 Mutations in CASP10 , intracellular apoptosis pathway AD Increased DN T cells Normal Defective lymphocyte apoptosis Adenopathies, splenomegaly, autoimmunity
ALPS–caspase 8 Mutations in CASP8 , intracellular apoptosis, and activation pathways AR Slightly increased DN T cells Normal Defective lymphocyte apoptosis and activation Adenopathies, splenomegaly, bacterial and viral infections, hypogammaglobulinemia
FADD deficiency Mutations in FADD encoding an adaptor molecule interacting with FAS, and promoting apoptosis AR Increased DN T cells Normal Defective lymphocyte apoptosis Functional hyposplenism, bacterial and viral infections, recurrent episodes of encephalopathy and liver dysfunction

AD, autosomal dominant; AR, autosomal recessive; CTL, cytotoxic T lymphocyte; IBD, inflammatory bowel disease; NK, natural killer cell; XL, X-linked.


Immunodeficient Patient


Approximately 5-10% of children with recurrent infections have an underlying immunodeficiency. Frequently, the onset of infections occurs between the ages of 6 and 12 months, but delays in diagnosis are not uncommon. In addition, certain immune deficiencies such as common variable immunodeficiency disease (CVID) can present in adolescence or young adulthood; thus it is critical to consider immune defects in children of any age. Infections in patients with primary immune deficiencies often vary in type, location, and severity, although sinopulmonary infections are common. Failure to thrive may occur and can be a sign of a serious immune defect. Patients with primary immune defects often require repeated courses of antibiotics or intravenous antibiotics, or may have infections with unusual organisms or exhibit unexpected complications. Such children may respond to antibiotics but become ill when the medications are discontinued.


Diagnostic Approach to the Patient with Recurrent Infections


Patients with recurrent, severe, or unusual infections involving multiple sites or organ systems should be investigated for an immunodeficiency ( Fig. 41.1 ). Initial tests are recommended for patients suspected of a primary immune deficiency, although a variety of immune defects can occur despite normal screening tests. Thus it is recommended that advanced testing be performed in consultation with a clinical immunologist.




FIGURE 41.1


Initial work-up and follow-up studies of patients with suspected immune deficiency. Consultation with a clinical immunologist is recommended to guide advanced testing and interpret results. CBC, complete blood count; CGD, chronic granulomatous disease; LAD, leukocyte adhesion defect; NK, natural killer cell; IL, interleukin; IFN, interferon.


A complete blood count with manual differential should always be obtained in the evaluation of any child suspected of immunodeficiency. A neutrophil count below 500/mm 3 might indicate severe congenital neutropenia, cyclic neutropenia, idiopathic neutropenia, marrow failure, or replacement of marrow by leukemia or a tumor if other hematopoietic cell lines are affected. Analysis of the peripheral blood smear is important as this can detect neutrophil abnormalities (e.g., abnormal granules in Chédiak-Higashi) or evidence of asplenia (i.e., Howell-Jolly bodies).


Serum immunoglobulin levels (IgG, IgA, IgM, IgE) are essential to the work-up of suspected primary immunodeficiency. Antibody levels vary with age, with normal adult values of IgG at birth from transplacental transfer of maternal IgG, a physiologic nadir occurring between 3 and 6 months of age, and a gradual increase to adult values over several years. IgA and IgM are low at birth and levels increase gradually over several years, with IgA taking the longest to reach normal adult values. When IgG levels are low, albumin levels should be measured because increased loss of proteins, as in protein-losing enteropathy or nephrotic syndrome, can result in hypogammaglobulinemia. High immunoglobulin levels suggest intact B cell immunity and can be found in diseases with recurrent infections, such as chronic granulomatous disease (CGD), immotile cilia syndrome, cystic fibrosis, HIV infection, autoimmune diseases (lupus), and other disorders leading to chronic inflammation. Elevated IgE levels can be found in a number of immune deficiencies such as hyper-IgE syndrome, but more likely represent atopic diseases (atopic dermatitis).


Specific antibody titers after childhood vaccination (tetanus, diphtheria, Haemophilus influenzae type b, or Streptococcus pneumoniae ) reflect the capacity of the immune system to synthesize specific antibodies and to develop memory B cells. If titers are low, immunization with a specific vaccine and obtaining titers 4-6 weeks later should be performed to confirm a response to the immunization. Poor response to bacterial polysaccharide antigens is often found before 24 months of age; even in older individuals the antibody response to polysaccharide vaccines is typically less robust and less long-lived than protein antigens. The development of protein-conjugate polysaccharide vaccines to Streptococcus pneumoniae and Haemophilus influenzae has dramatically reduced invasive infections with these organisms in early childhood by improving the response to vaccination. Antibody responses to the S. pneumoniae serotypes found in the 23-valent polysaccharide vaccine, but not in the conjugate vaccine, can be used to test antibody responses to polysaccharide antigens.


Complement assays include the CH50 test, which measures the presence of proteins in the classical pathway of complement (C1, C2, C3, C4), and the AH50 test, which tests the proteins of the alternative pathway of complement (C3, factor B, properdin). In patients with deficiencies in complement protein, the CH50 levels or AH50 levels are generally zero, whereas they are low but not absent in disorders leading to complement consumption (e.g., systemic lupus erythematosus). If both the CH50 and AH50 levels are abnormal, a defect in the common pathway is likely (C5-C9). Specialized laboratories can measure the presence or function of specific complement proteins.


If the above studies are normal but a primary immune deficiency is still suspected, advanced studies can be performed. One such advanced study is flow cytometry to enumerate the percentage and absolute numbers of T cells, B cells and markers of B cell maturation, and NK cell subsets. Flow cytometry can also test for the presence of surface proteins that are necessary for normal immunity, such as major histocompatibility complex molecules or adhesion molecules. Functional T cell tests include T cell proliferation assays in response to mitogens (phytohemagglutinin or concanavalin A) or antigens (tetanus toxoid or Candida ). These in vitro assays assess the capacity of T cells to proliferate in response to a nonspecific stimulus (mitogens) or antigen-specific memory T cells (antigens). T cell proliferation in response to specific antigens requires a prior exposure to that unique antigen. Delayed-type hypersensitivity skin tests to protein antigens such as tetanus, diphtheria, Candida, or mumps demonstrate the presence and function of both antigen-specific T cells and antigen-presenting cells. If delayed-type hypersensitivity skin test results are negative, one may consider a booster vaccination and retesting 4 weeks later.


Tests for neutrophil function include the nitroblue tetrazolium (NBT) or dihydrorhodamine 123 (DHR) test for CGD. In the NBT test, oxygen radicals generated by activated neutrophils oxidize NBT to an insoluble dark blue dye that can be detected in neutrophils by microscopic examination. In the DHR test, oxygen radicals generated by activated neutrophils oxidize DHR, which results in the emission of light that is detected by flow cytometry. Neutrophils that are activated in patients with CGD cannot generate oxygen radicals and therefore have an abnormal NBT test (no blue neutrophils) or DHR test (no increase in light emitted from activated neutrophils).


Genetic testing to confirm the diagnosis of a primary immunodeficiency disease can be performed in specialized laboratories and may be helpful for deciding on a course of treatment, determining the natural history and prognosis of the disease, and to allow for genetic counseling. Chromosomal deletion/duplication microarrays are increasingly used to diagnose specific syndromic disorders that may have immunodeficiency due to genomic copy number variants (CNV) such as DiGeorge Syndrome. Specific gene or multiple gene sequencing is available commercially. With the advent of next generation sequencing techniques, it is now possible to sequence nearly all the genes in a subject. Because there are hundreds of genes known to cause primary immune deficiencies, this technology is being used in the diagnosis of primary immune deficiencies.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Apr 4, 2019 | Posted by in PEDIATRICS | Comments Off on Recurrent Fever, Infections, Immune Disorders, and Autoinflammatory Diseases

Full access? Get Clinical Tree

Get Clinical Tree app for offline access